Quality-of-life (QOL) analyses in patients with multiple myeloma: Results from the selinexor (KPT-330) treatment of refractory myeloma (STORM) phase IIb study. This is an ASCO Meeting Abstract from ...
A new technical paper, “Quantifying Uncertainty in FMEDA Safety Metrics: An Error Propagation Approach for Enhanced ASIC Verification,” was published by Robert Bosch GmbH.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results